← FDA Drug Approvals (Drugs@FDA)
ZOLEDRONIC ACID
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2020-02-19
Drug application
- FDA Application #
ANDA208968- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ZOLEDRONIC ACID
- Generic name
- Zoledronic Acid
- Active ingredients
- ZOLEDRONIC ACID
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- NOVAST LABS
- First approval
- 2020-02-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown